These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 8625324)
21. A case of malignant schwannoma with overexpression of multidrug resistance gene (MDR1) after chemotherapy. Suto R; Abe Y; Lee YH; Ueyama Y; Yamazaki H; Kijima H; Hiraoka N; Fukuda H; Tamaoki N; Nakamura M Anticancer Res; 1997; 17(3C):2273-7. PubMed ID: 9216701 [TBL] [Abstract][Full Text] [Related]
22. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608 [TBL] [Abstract][Full Text] [Related]
23. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275 [TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein expression and prognostic value in acute myeloid leukemia. Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574 [TBL] [Abstract][Full Text] [Related]
26. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma. Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms. Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112 [TBL] [Abstract][Full Text] [Related]
29. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A; Priebsch A; Nieth C; Lage H Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376 [TBL] [Abstract][Full Text] [Related]
30. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341 [TBL] [Abstract][Full Text] [Related]
31. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. Si M; Zhao J; Li X; Tian JG; Li YG; Li JM Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684 [TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709 [TBL] [Abstract][Full Text] [Related]
33. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line. Wang Z; Xia Q; Cui J; Diao Y; Li J Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927 [TBL] [Abstract][Full Text] [Related]
34. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance. Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872 [TBL] [Abstract][Full Text] [Related]
35. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311 [TBL] [Abstract][Full Text] [Related]
36. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266 [TBL] [Abstract][Full Text] [Related]
37. Expression of the multidrug resistance gene in osteosarcoma: a pilot study. Wunder JS; Bell RS; Wold L; Andrulis IL J Orthop Res; 1993 May; 11(3):396-403. PubMed ID: 8100852 [TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019 [TBL] [Abstract][Full Text] [Related]
39. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Berlin O; Samid D; Donthineni-Rao R; Akeson W; Amiel D; Woods VL Cancer Res; 1993 Oct; 53(20):4890-5. PubMed ID: 8402677 [TBL] [Abstract][Full Text] [Related]
40. Regulation of the multidrug resistance (MDR1) gene expression. Chin KV; Liu B In Vivo; 1994; 8(5):835-41. PubMed ID: 7727733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]